Back
Direxion Daily S&P 500® Hi Bt Br 3X ETF Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
17
HIBS
Direxion Daily S&P 500® Hi Bt Br 3X ETF
Last Price:
16.50
Seasonality Move:
-28.99%
Sell
49
SRPT
Sarepta Therapeutics
Last Price:
130.47
Seasonality Move:
14.88%
Sell
17
Direxion Daily S&P 500® Hi Bt Br 3X ETF (HIBS)
is a Sell
Is Direxion Daily S&P 500® Hi Bt Br 3X ETF a Buy, Sell or Hold?
- The current Direxion Daily S&P 500® Hi Bt Br 3X ETF [HIBS] share price is $16.50. The Score for HIBS is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- HIBS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HIBS Stock Price Chart
What is Direxion Daily S&P 500® Hi Bt Br 3X ETF's stock price today?
-
The Direxion Daily S&P 500® Hi Bt Br 3X ETF share price today is $16.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HIBS is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $130.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
HIBS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 37.9 | Sell |
Chaikin Money Flow: | 95063 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.31 - 19.87) | Sell |
Bollinger Bands (100): | (18.3 - 24.52) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.3 | Sell |
Relative Strength Index (14 RSI): | 64.59 | Buy |
Chaikin Money Flow: | 3149400 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.02 - 128.88) | Buy |
Bollinger Bands (100): | (119.18 - 142.3) | Sell |
HIBS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.94 | Sell |
20-day SMA: | 18.48 | Sell |
50-day SMA: | 18.9 | Sell |
200-day SMA: | 23.29 | Sell |
8-day EMA: | 17.42 | Sell |
20-day EMA: | 18.14 | Sell |
50-day EMA: | 19.3 | Sell |
200-day EMA: | 24.78 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.07 | Buy |
20-day SMA: | 117.27 | Buy |
50-day SMA: | 121.92 | Buy |
200-day SMA: | 129.99 | Buy |
8-day EMA: | 116.28 | Buy |
20-day EMA: | 117.14 | Buy |
50-day EMA: | 121.91 | Buy |
200-day EMA: | 125.98 | Buy |
Direxion Daily S&P 500® Hi Bt Br 3X ETF Earnings Growth & HIBS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.
Direxion Daily S&P 500® Hi Bt Br 3X ETF Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |